UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 27, 2025
VSEE HEALTH, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-41015 | 86-2970927 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
980 N Federal Hwy #304 Boca Raton, Florida |
33432 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (561) 672-7068
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol |
Name of each exchange on which registered |
||
Common Stock, $0.0001 par value per share | VSEE | The Nasdaq Stock Market LLC | ||
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share | VSEEW | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 7.01. Regulation FD Disclosure.
On January 27, 2025, VSee Health, Inc. (the “Company”) issued a press release announcing a contract renewal of approximately $870K with a nationwide provider of mental and behavioral healthcare services. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
The information included in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall this item and Exhibit 99.1 be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit | Description |
99.1 | Press Release, dated January 27, 2025 |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 30, 2025 | VSEE HEALTH, INC. | |
By: | /s/ Imoigele Aisiku | |
Name: | Imoigele Aisiku | |
Title: | Co-Chief Executive Officer |
Exhibit 99.1
VSee Health Announces $870K Contract with National Mental Health Services Company
SAN JOSE, Calif.--January 27, 2025--VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive digital health services and customized telehealth workflow streams, announces a contract renewal of approximately $870K with a nationwide provider of mental and behavioral healthcare services. This renewal underscores VSee’s exceptional client retention and the unmatched value of its platform in enabling the delivery of high-quality mental healthcare solutions.
“Now more than ever, telehealth is an essential part of providing mental and behavioral health services,” notes Dr. Milton Chen, Co-CEO of VSee Health. “VSee is dedicated to delivering simple, secure, high-quality video that is foundational to providing virtual mental health care. Moreover, this renewal reflects our continued commitment to advance mental health care through impactful technology including AI tools to optimize clinician workflows and improve outcomes for all.”
VSee is recognized for the flexibility and scalability of its platform. Through the use of its lego-like digital health building blocks, VSee provides fast deployment of workflows designed for mental and behavioral health such as PHQ-9 and GAD-7 assessments, custom intake forms, automated client-provider state-matching, anonymized group calls, and a simple no-download patient experience.
VSee Growth Potential in TeleMental and TeleBehavioral Health
The digital mental health market is expected to grow from $23.63 billion in 2024 to $27.56 billion in 2025, with a CAGR of 16.6%, according to The Business Group. This growth is attributed to the rise of mental health disorders and the increasing adoption of telehealth services and digital mental health tools. VSee is poised to take advantage of this growth with its secure, scalable, ready-to-customize digital health platform with seamless integration and actionable data insight capabilities.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects, “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company’s ability to regain compliance with Nasdaq’s listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC’s website at www.sec.gov . The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
About VSee Health
VSee Health’s AI telehealth platform is the fastest way for enterprises to go from ideation to market go-live. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, its customizable building blocks meet stringent government security standards, and are ready to scale. VSee Health has traveled for field deployments to over 50 countries such as Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA Space Station, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar.
VSee Health offerings also include turnkey solutions for critical shortage areas such as critical care and teleradiology. It is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. Visit vseehealth.com.
Contacts
Media Contact:
VSee Health
Anne Chang
626-513-1824
media@vsee.com
Investor Contact:
Dave Gentry
RedChip Companies
1-407-644-4256